Skip to Main Content

Effective October 1, 2021: Clinical Policies

Date: 07/30/21

Superior HealthPlan has updated or retired certain clinical policies to ensure medical necessity review criteria is current and appropriate for members and the scope of services provided. As a result the following policies are effective on October 1, 2021, at 12:00AM.

POLICY

APPLICABLE PRODUCTS

NEW POLICY OVERVIEW OR UPDATED POLICY REVISIONS

Bariatric Surgery

CP.MP.37

Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS) CHIP

Policy revisions include:

  • Section I:
    • Added BMI criteria for Asian ethnicity to IA.1.a, I.A.1.b and I.A.1.c
    • Added high risk of T2D to list of severe obesity related complications
    • Added “inadequate glycemic control…” to I.A.1.c.i
  • Section II:
    • Removed criteria for ECG during cardiac clearance except for high risk
    • In II.B, added note about medical director review if A1C ≥8
    • Removed requirement of chest x-ray and specific criteria for PSG, noting that PSG is warranted if OSA screening is positive in II.C
    • Pulmonary Evaluation
      • added examples of nutritional tests to be conducted, and that malabsorptive procedures may require further testing to section II.D
      • removed requirement of 1 year abstinence of drug & alcohol use and urine drug screen if history of abuse in II.F
      • added “current drug and alcohol abuse” to list of contraindications
      • added clinically significant GI symptoms should be evaluated & treated prior to surgery in II.I
  • In III.A.2.e, removed option for non-compliance with post-operative regimen if completing a multidisciplinary bariatric program
  • In III.A.2.f., removed option for non-compliance
  • Reworded V
    • replacing “investigational” with “current medical literature is inadequate to determine the safety, efficacy and long-term outcomes”
    • added to the list
      • one-anastomosis gastric bypass
      • endoscopic sleeve gastroplasty
      • transoral endoscopic surgery
      • vagus nerve blocking (e.g., Maestro)
      • gastric balloon (e.g., ReShape Duo Orbera intagastic balloonObalon Balloon)

Added the following CPT codes as not supporting medical necessity: 43648, 43882, 64595, 0312T, 0313T, 0314T, 0315T, 0316T and 0317T

Carrier Screening in Pregnancy

CP.MP.83

Ambetter

Policy Retired:

  • The policy is being retired and Superior HealthPlan has chosen to review these services per Change Healthcare’s InterQual criteria.  The criteria is proprietary, but further information is available upon request

NICU Discharge Guidelines

CP.MP.81

Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS) CHIP and Ambetter

 

Policy revisions include:

  • Added I.A.3 regarding weight lost in preterm infants less than a week old
  • Added a note regarding gastrostomy tube placement recovery/education to I.B.2.d.ii
  • Updated II.A with temperature range and in note changed 1600 grams to1800 grams
  • Added “Chronic Lung Disease/” to “Bronchopulmonary dysplasia” for condition in III.B.3.a
  • Added note under III.B.3.b.i explaining stability on home ventilator in hospital prior to discharge
  • Removed V.A and B, updating the “free of infection” criteria statement  Added new section VI regarding caregiver competency
  • In section VII
    • clarified in A “should be approved for any of….”
    • added A.5 regarding caffeine for apnea
    • added B regarding parent/caregiver refusal to sign
    • added C.1 and 2 regarding nondenial of care
    • updated the note under describing rooming-in
  • In Discharge Recommended Practices
    • added “immunoglobulin” to C.2
    • updated C.3 with influenza injection
    • added “hospital developed education program” under D
    • added E.1-4 regarding car seats

Sacroiliac Joint Interventions for Pain Management

CP.MP.166

Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS) CHIP and Ambetter

 

Policy revisions include:

  • Updated I.A. to specify that the criteria applies to therapeutic injections as well as diagnostic
  • Updated I.B. to state “A second diagnostic or confirmatory sacroiliac joint injection when pain was improved by at least 75% after the first diagnostic SIJ injection”, rather than that pain did not improve
  • I.C. was updated to specify “therapeutic” SIJ injection
  • II was changed from 50% to 75%

To review all policies, please visit Superior’s Clinical, Payment & Pharmacy Policies webpage.

Prior to updates, Medical Clinical policies are reviewed and approved by the Utilization Management Committee.

For questions or additional information, contact Superior HealthPlan Prior Authorization department at 1-800-218-7508.